A Two-part Multiple Dose Study to Assess the Safety and Effects of AZD3293 in Healthy Elderly and Alzheimer's Patients

Clinical trial NCT01795339 · COMPLETED

Trial details

NCT number: NCT01795339
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Elderly Volunteers Mild-to-moderate Alzheimer's Disease Patients

Start date: 2013-03-01
Primary completion: 2014-03-01
Enrollment: 47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.